Bio-Rad Laboratories Inc (BIO-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bio-Rad Laboratories Inc (BIO-B) has a cash flow conversion efficiency ratio of 0.016x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($108.10 Million) by net assets ($6.85 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Bio-Rad Laboratories Inc worth for the company's overall valuation and market capitalisation.
Bio-Rad Laboratories Inc - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Bio-Rad Laboratories Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Bio-Rad Laboratories Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio-Rad Laboratories Inc ranked by their cash flow conversion efficiency. Explore cash flow quality index of Bio-Rad Laboratories Inc to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Pan Jit International Inc
TW:2481
|
0.038x |
|
Lianhe Chemical Technology Co Ltd
SHE:002250
|
0.079x |
|
ChipMOS Technologies
TW:8150
|
0.043x |
|
Inner Mongolia Furui Med Sci
SHE:300049
|
0.056x |
|
ATS CORP.
F:ATO0
|
-0.006x |
|
Zhe Jiang Dong Ri Ltd Co
SHG:600113
|
0.026x |
|
Carabao Group Public Company Limited
BK:CBG-R
|
0.092x |
|
Winpak Ltd.
TO:WPK
|
0.005x |
Annual Cash Flow Conversion Efficiency for Bio-Rad Laboratories Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of Bio-Rad Laboratories Inc from 1989 to 2025. View Bio-Rad Laboratories Inc share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.45 Billion | $532.20 Million | 0.071x | +3.04% |
| 2024-12-31 | $6.57 Billion | $455.20 Million | 0.069x | +61.54% |
| 2023-12-31 | $8.74 Billion | $374.94 Million | 0.043x | +112.11% |
| 2022-12-31 | $9.62 Billion | $194.45 Million | 0.020x | -58.66% |
| 2021-12-31 | $13.69 Billion | $669.46 Million | 0.049x | -17.38% |
| 2020-12-31 | $9.88 Billion | $584.97 Million | 0.059x | -25.58% |
| 2019-12-31 | $5.76 Billion | $457.90 Million | 0.080x | +12.04% |
| 2018-12-31 | $4.02 Billion | $285.49 Million | 0.071x | +99.82% |
| 2017-12-31 | $2.93 Billion | $104.14 Million | 0.036x | -57.58% |
| 2016-12-31 | $2.58 Billion | $216.07 Million | 0.084x | +12.04% |
| 2015-12-31 | $2.49 Billion | $186.21 Million | 0.075x | -40.22% |
| 2014-12-31 | $2.19 Billion | $273.31 Million | 0.125x | +61.71% |
| 2013-12-31 | $2.19 Billion | $169.14 Million | 0.077x | -41.50% |
| 2012-12-31 | $2.02 Billion | $266.48 Million | 0.132x | -12.22% |
| 2011-12-31 | $1.74 Billion | $262.74 Million | 0.151x | +2.71% |
| 2010-12-31 | $1.54 Billion | $225.91 Million | 0.147x | -42.29% |
| 2009-12-31 | $1.28 Billion | $325.07 Million | 0.254x | +42.17% |
| 2008-12-31 | $1.07 Billion | $191.37 Million | 0.179x | -9.34% |
| 2007-12-31 | $971.69 Million | $191.58 Million | 0.197x | +36.67% |
| 2006-12-31 | $819.54 Million | $118.23 Million | 0.144x | -12.34% |
| 2005-12-31 | $657.97 Million | $108.28 Million | 0.165x | -20.20% |
| 2004-12-31 | $596.89 Million | $123.09 Million | 0.206x | -19.89% |
| 2003-12-31 | $495.81 Million | $127.64 Million | 0.257x | -6.75% |
| 2002-12-31 | $383.09 Million | $105.76 Million | 0.276x | -21.23% |
| 2001-12-31 | $283.88 Million | $99.50 Million | 0.350x | +253.59% |
| 2000-12-31 | $244.62 Million | $24.25 Million | 0.099x | -51.52% |
| 1999-12-31 | $220.10 Million | $45.00 Million | 0.204x | +60.49% |
| 1998-12-31 | $214.30 Million | $27.30 Million | 0.127x | +18.76% |
| 1997-12-31 | $196.70 Million | $21.10 Million | 0.107x | -40.71% |
| 1996-12-31 | $183.50 Million | $33.20 Million | 0.181x | -25.59% |
| 1995-12-31 | $157.10 Million | $38.20 Million | 0.243x | -34.65% |
| 1994-12-31 | $129.80 Million | $48.30 Million | 0.372x | +82.42% |
| 1993-12-31 | $110.30 Million | $22.50 Million | 0.204x | +446.18% |
| 1992-12-31 | $107.10 Million | $4.00 Million | 0.037x | -17.29% |
| 1991-12-31 | $90.80 Million | $4.10 Million | 0.045x | -69.74% |
| 1990-12-31 | $81.10 Million | $12.10 Million | 0.149x | +4.90% |
| 1989-12-31 | $68.90 Million | $9.80 Million | 0.142x | -- |
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, pu… Read more